Dr. Francis on Ovarian Suppression for Younger Women With HR+ Breast Cancer

Описание к видео Dr. Francis on Ovarian Suppression for Younger Women With HR+ Breast Cancer

Prudence Francis, MD, from the Peter MacCallum Cancer Centre in Victoria, Australia, discusses the SOFT trial, which examined suppression of ovarian function, and the impact it could have on the future treatment of women under 35 with hormone receptor-positive breast cancer.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке